ABG Acquisition Corp. I (Nasdaq:ABGI) is a blank check company, or special purpose acquisition company (SPAC), formed to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses, with a focus on the healthcare and healthcare-related industries; it offers no current products or services beyond capital raising through its initial public offering, strategic partnerships for public market access, advisory on growth strategies, and post-merger integration support for target companies in sectors including healthcare, technology, and environmental, social, and governance-focused enterprises. Founded in 2020 and headquartered in New York, New York, the company targets private firms with strong management teams, growth potential, and alignment with market trends across North America and potentially global operations post-combination. In February 2023, ABG Acquisition Corp. I announced the redemption of its public shares and liquidation after failing to complete an initial business combination within the required timeframe, resulting in the cancellation of its Class A ordinary shares as of February 27, 2023, and rendering the entity defunct.